The biotech industry thrives due to consistent innovation and steady demand for advanced healthcare. An aging population and the need for high-quality treatments for rare and common diseases back the optimism surrounding the industry.
Therefore, investors could consider investing in fundamentally strong biotech stocks Puma Biotechnology, Inc. (PBYI), Alnylam Pharmaceuticals, Inc. (ALNY), and Genmab A/S (GMAB).
